Navigation Links
PrimeraDx Appoints Jeff Liter as VP of Corporate Development
Date:10/13/2011

MANSFIELD, Mass., Oct. 13, 2011 /PRNewswire/ -- PrimeraDx today announced that Jeff Liter has been appointed as the Vice President of Corporate Development.  

"Jeff's diverse background in all aspects of corporate development makes him a great addition to the leadership team," Said Matt McManus, President and CEO, PrimeraDx.  "PrimeraDx's strategy is to leverage the multimodal capabilities of the ICEPlex system in the MDx market and define a model for the next generation of molecular diagnostics.  Jeff has a great deal of experience that will help bring scale to our commercial efforts."

Mr. Liter has more than 20 years of experience in business development, sales, corporate finance and operations.  Prior to joining PrimeraDx, he was the Director of Strategy, Business Development, & Licensing for Beckman Coulter, where he was responsible for Business Development of the Immunoassay and Molecular Diagnostics Groups.  Jeff also was the managing director with On Point Consulting, focusing on Post Acquisition Integration Support and Transactional Advisory Services.  Specifically, he delivered integration services to Onyx Pharmaceuticals and established a Knowledge Transfer Program within the first 3 months of a critical integration.  He received his MBA from University of Minnesota and his BA from Illinois State University.

"The ICEPlex platform is already creating a stir in the MDx community, with the ability to assay mRNAs, microRNAs and SNPs in the same well, from a single sample," Commented Mr. Liter.  "I am excited to work with Matt and the team, to develop the company's customer base and strategic alliances."

About PrimeraDx

PrimeraDx is dedicated to the high growth field of molecular diagnostics.  The Company has developed a unique platform for high-multiplex, quantitative, real-time PCR based on its proprietary STAR technology, implemented on the walk-away ICEPlex® instrument system.  PrimeraDx is developing a broad range of applications in oncology, infectious disease, companion diagnostics and multiple non-clinical molecular markets, both through its own efforts and in collaboration with partners.  The Company is backed by a strong group of experienced venture-capital investors, including Abingworth, InterWest Partners, CHL Medical Partners, and Malaysia Technology Development Corporation.  The Company's website is: www.primeradx.com or www.multiplexpcr.com.

CONTACT: Andrew Bond, +1-508-618-2752, abond@primeradx.com


'/>"/>
SOURCE PrimeraDx
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. PrimeraDx Names Fayyaz Memon Vice President of Regulatory Affairs and Quality Assurance
2. PrimeraDx Appoints Albert A. Luderer to its Board of Directors
3. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
4. Omeros Appoints David A. Mann to its Board of Directors
5. RainDance Technologies Appoints Olex Vice President, System Development
6. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
7. WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility
8. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
9. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
10. RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer
11. UltraShape Appoints Assaf Eyal as President & CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... , ... May 03, 2016 , ... ... enterprise talent development, skill-building and compliance training platform on mobile devices, today released ... Overview of Regulatory Requirements for Medical Devices. The course is essential for owners ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... unique bioresearch materials from laboratories across the globe, today announced the availability of ... the pace of research toward treatment and prevention measures for the Zika virus, ...
(Date:5/3/2016)... York, NY (PRWEB) , ... May 03, 2016 , ... ... Hill Hospital , for definitive prostate cancer treatment, patients traditionally had two main treatment ... appropriate treatment plan would be made. , New technology has enabled doctors to ...
(Date:5/2/2016)... ... May 02, 2016 , ... StarNet Communications Corp, ( http://www.starnet.com/ ) a leading ... Secure Remote Desktop modules to its flagship X-Win32 PC X server. The new ... to the user’s PC over encrypted SSH. , Traditionally, users of PC X servers ...
Breaking Biology Technology:
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
Breaking Biology News(10 mins):